open access
Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma
open access
Abstract
Abstract
Keywords
tall cell variant, papillary thyroid carcinoma, prognostic risk factors
Title
Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma
Journal
Issue
Article type
Original paper
Pages
623-630
Published online
2017-09-18
Page views
2100
Article views/downloads
1482
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2017;68(6):623-630.
Keywords
tall cell variant
papillary thyroid carcinoma
prognostic risk factors
Authors
Kursat Okuyucu
Engin Alagoz
Semra Ince
Nuri Arslan
- Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976; 43(4): 207–215.
- Jalisi S, Ainsworth T, Lavalley M. Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis. J Thyroid Res. 2010; 2010: 325602.
- Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988; 12(1): 22–27.
- Rüter A, Nishiyama R, Lennquist S. Tall-cell variant of papillary thyroid cancer: disregarded entity? World J Surg. 1997; 21(1): 15–20; discussion 20.
- Michels JJ, Jacques M, Henry-Amar M, et al. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol. 2007; 38(2): 212–219.
- Ghossein RA, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid. 2007; 17(7): 655–661.
- Segal K, Friedental R, Lubin E, et al. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg. 1995; 113(4): 356–363.
- Adeniran AJ, Zhu Z, Gandhi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J SurgPathol. 2006; 30(2): 216–222.
- Ghossein R, Livolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 2008; 18(11): 1179–1181.
- Burman KD, Ringel MD, Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am. 1996; 25(1): 49–68.
- Rivera M, Ghossein RA, Schoder H, et al. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 2008; 113(1): 48–56.
- Leung AKC, Chow SM, Law SCK. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Laryngoscope. 2008; 118(1): 32–38.
- Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 2002; 27(3): 143–148.
- Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 2000; 88(8): 1902–1908, doi: 10.1002/(sici)1097-0142(20000415)88:8<1902::aid-cncr20>3.3.co;2-p.
- Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008; 132(8): 1241–1250.
- Wreesmann VB, Sieczka EM, Socci ND, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004; 64(11): 3780–3789.
- Campo E, Merino MJ, Liotta L, et al. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol. 1992; 23(12): 1395–1401.
- LiVolsi VA. Papillary carcinoma tall cell variant (TCV): a review. Endocr Pathol. 2010; 21(1): 12–15.
- LiVolsi VA. Surgical Pathology of the Thyroid. Philadelphia: WB Saunders Company. ; 1990: 136–163.
- Terry JH, St John SA, Karkowski FJ, et al. Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg. 1994; 168(5): 459–461.
- Ain KB. Papillary thyroid carcinoma. Etiology, assessment, and therapy. Endocrinol Metab Clin North Am. 1995; 24(4): 711–760.
- Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 1996; 20(8): 964–974.
- Moreno Egea A, Rodriguez Gonzalez JM, Sola Perez J, et al. Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol. 1993; 19(6): 517–521.
- Prendiville S, Burman KD, Ringel MD, et al. Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg. 2000; 122(3): 352–357.
- Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993; 114(6): 1050–7; discussion 1057.
- Ito Y, Hirokawa M, Uruno T, et al. Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology. 2008; 40(6): 617–622.
- Bocklage T, DiTomasso JP, Ramzy I, et al. Tall cell variant of papillary thyroid carcinoma: cytologic features and differential diagnostic considerations. Diagn Cytopathol. 1997; 17(1): 25–29, doi: 10.1002/(sici)1097-0339(199707)17:1<25::aid-dc5>3.3.co;2-w.
- Wenig BM, Thompson LD, Adair CF, et al. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer. 1998; 82(4): 740–753, doi: 10.1002/(sici)1097-0142(19980215)82:4<740::aid-cncr18>3.0.co;2-y.
- Evans C, Tennant S, Perros P, et al. Thyroglobulin in differentiated thyroid cancer. Clin Chim Acta. 2015; 444: 310–317.
- Zucchelli G, Iervasi A, Ferdeghini M, et al. Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2009; 53(5): 482–489.